The Cdk inhibitor p21 WAF1/CIP1 is a negative regulator of the cell cycle, although its expression is induced by a number of mitogens that promote cell proliferation. We have found that E2F1 and E2F3, transcription factors that activate genes required for cell cycle progression, are strong activators of the p21 promoter. In contrast, HBP1 (HMG-box protein-1), a novel retinoblastoma protein-binding protein, can repress the p21 promoter and inhibit induction of p21 expression by E2F. Both E2Fs and HBP1 regulate p21 transcription through cisacting elements located between nucleotides 7119 to +16 of the p21 promoter and the DNA binding domains of each of these proteins are required for activity. Sequences between 7119 and 760 basepairs containing four Sp1 consensus elements and two noncanonical E2F binding sites are of major importance for E2F activation, although E2F1 and E2F3 dier in the extent of their ability to activate expression when this segment is deleted. The opposing eects of E2Fs and HBP1 on p21 promoter activity suggest that interplay between these factors may determine the level of p21 transcription in vivo.
Introduction

p21
WAF1/CIP1 (El-Deiry et al., 1993; Harper et al., 1993; Jiang et al., 1994; Noda et al., 1994; Xiong et al., 1993) , can bind and inhibit G 1 cyclin/cyclin-dependent kinase (Cdk) complexes (Harper et al., 1993; Xiong et al., 1993) leading to growth suppression (Lin et al., 1996a) . Exit from the cell cycle is a prerequisite for terminal dierentiation, and p21 expression is induced during terminal dierentiation in a number of systems (Halevy et al., 1995; Jiang et al., 1994; Macleod et al., 1995; Parker et al., 1995; Steinman et al., 1994 ; for reviews see Gartel et al., 1996b; Gartel and Tyner, 1998) . In the adult small and large intestine, p21 expression is induced in epithelial cells as they migrate out of the crypts and begin to terminally dierentiate (Gartel et al., 1996a) . p21 mRNA and protein levels also increase in Caco-2 cells, which were derived from a colon adenocarcinoma, during dierentiation (Gartel et al., 1996a) . Caco-2 cells provide a useful in vitro model system for studying the induction of p21 transcription during dierentiation.
As Caco-2 cells dierentiate, expression of the transcription factor E2F1 initially increases, in parallel with p21 (Gartel et al., 1996a) . There are ®ve known E2F proteins which can heterodimerize with two DP proteins to form complexes capable of transcriptionally activating cellular genes encoding proteins required for cell cycle progression. Activity of these E2F proteins is negatively regulated by binding with the retinoblastoma protein (RB) or the RB related proteins p107 and p130 (for reviews, see Helin, 1998; Slansky and Farnham, 1996) . Phosphorylation of RB by an active Cdk/cyclin complex results in release of E2F and activation of genes required for cell cycle progression. Disruption of the E2F1 gene in mice resulted in increased proliferation of a number of cell types (Field et al., 1996; Yamasaki et al., 1996) , highlighting a possible role for E2F1 in the negative regulation of proliferation. These diverse studies underscore a potential dual role for E2F1 in positive and negative control of proliferation.
Recently, a novel RB and p130 binding protein termed HBP1 was cloned using a yeast two-hybrid screen (Tevosian et al., 1997) . Like p21, HBP1, RB, and p130 are ubiquitously expressed, but their expression speci®cally increases during dierentiation. HBP1 is a sequence-speci®c HMG box containing transcriptional repressor that can down-regulate transcription from the N-Myc promoter. In cycling cells, the N-Myc promoter is activated by E2Fs (Mudryj et al., 1990) . We have shown that E2F1-dependent activation can be counteracted by HBP1 and have suggested that E2F1 and HBP1 may constitute positive and negative transcriptional signals for the N-Myc promoter (Tevosian et al., 1997) . Additionally, HBP1 expression leads to cell cycle arrest, a necessary pre-requisite for terminal differentiation. The expression pattern and functions suggest that HBP1 may play a role in general cell differentiation (Tevosian et al., 1997) .
A number of transcription factors, including p53 (El-Deiry et al., 1993) , AP2 , BRCA1 , STATs (Chin et al., 1996; Matsumura et al., 1997) , C/EBP-a (Timchenko et al., 1996) , C/EBP-b (Chinery et al., 1997) , Spl (Biggs et al., 1996; Datto et al., 1995; Li et al., 1998; Prowse et al., 1997) and Sp3 (Prowse et al., 1997) have been shown to regulate transcription of the p21 gene. In this study, we have examined the ability of E2F family members and HBP1 to regulate p21 transcription. Our results suggest that E2F1/E2F3 and HBP1 have opposite eects and may modulate positive and negative regulation of the p21 promoter, respectively.
Results
Cis-acting elements located within 119 bp from the start site of p21 transcription are required for basal and E2F inducible transcription
To determine if E2F proteins can stimulate p21 transcription, Caco-2 cells were transfected with dierent E2F family expression constructs and CAT2330 which contains 2330 bp of the p21 promoter driving expression of a CAT reporter gene. Extracts were prepared and analysed for CAT activity. We found that both E2F1 and E2F3 are strong activators of the p21 promoter, while E2F4 did not have any eect on p21 transcription (Figure 1) .
To identify regions of the p21 promoter that are responsible for activation by E2F1 and E2F3, Caco-2 cells were transfected with p21 promoter-CAT constructs containing varying lengths of promoter sequence (Figure 2a ) and the E2F1 and E2F3 expression constructs. All p21 constructs tested, including the longest construct CAT2330 (72330 to +16 bp) and the shortest construct CAT119 (7119 to +16 bp), were activated by E2F1 (Figure 2b ). E2F3 was also capable of activating all p21 promoter constructs tested, and data with constructs having endpoints at 7595, 7296, 7133 and 7119 bp are shown in Figure 2b . From these experiments, we conclude that E2F1 and E2F3 responsive elements are located between positions 7119 and +16 bp of the p21 promoter.
To further localize cis-acting elements within the p21 promoter that mediate activation by E2F1 and E2F3, we transfected Caco-2 cells with the p21 promoter-CAT reporter constructs CAT102 (7102 to +16 bp) and CATD 7124/760 (7156 to +16 bp with a deletion of sequences between 7124 and 760 bp) and the E2F1 and E2F3 expression constructs. Basal transcription of the CAT102 and CATD 7124/760 constructs was almost totally impaired, as can been seen when these two reporters are transfected with the empty expression vector (V) as a control (Figure 3b ). This suggests that the two Sp1 sites located between 7102 and 7119 bp are important for regulating basal transcription. In contrast to the reporter CATD 7124/ 760, the reporter CAT102 was highly inducible by E2F1 and E2F3. The construct CATD 7124/760 was 10-fold more inducible by E2F3 than by E2F1 ( Figure  3b ). This construct contains two additional Sp1 sites located between 760 and 750 bp, which appear to be important for transactivation by E2F3, but not for E2F1.
The E2F1 DNA and Sp1 binding domains are both required for high level induction of p21 promoter activity
To quantitatively estimate the degree of activation of the minimal p21 promoter by E2F1 and E2F3, we cotransfected a series of dierent concentrations of the E2F1 and E2F3 expression constructs with a constant amount of the reporter plasmid CAT119. We found that E2F1 activates the minimal p21 promoter 15 ± 20-fold ( Figure 4a ) and E2F3 activates this same construct 10 ± 15 times (data not shown). The degree of activation is not signi®cantly dependent upon E2F1 and E2F3 concentrations.
To further investigate the mechanism of transactivation of the p21 promoter by E2F1, we used two E2F1 mutants: E132 with a point mutation in the DNAbinding domain (Shin et al., 1996) , and d113 ± 120
Figure 1 E2F1 and E2F3 transactivate the p21 promoter in Caco-2 cells. CAT assays were performed with extracts from Caco-2 cells transfected with the empty vector or the E2F1, E2F3, and E2F4 expression constructs and the CAT 2330 p21 promoter reporter construct. Transfections were performed in duplicate for each experiment, and each experiment was repeated at least three times. A typical experiment is shown Figure 2 Cis-acting sequences between 7119 and +16 bp mediate induction of the p21 promoter by E2F1 and E2F3. (a) Dierent promoter-deletion constructs of the human p21 promoter in the pJFCAT1 vector. (b) CAT assays were performed with extracts from Caco-2 cells transiently transfected with the E2F1 expression construct or the vector control and p21 promoter-deletion constructs with endpoints extending from 72230 to 7119 bp of the p21 gene. CAT assays were also performed with extracts from Caco-2 cells transiently transfected with the E2F3 expression constructs and p21 promoter-deletion constructs with endpoints extending from 7589 to 7119 bp. A typical experiment is shown containing a deletion in the Sp1-binding domain (Lin et al., 1996b) . We found that the DNA-binding mutant E132 lost its ability to transactivate the p21 promoter, and the Sp1-binding mutant was less active than wild type E2F1 (Figure 4b ). These data suggest that E2F1 binds the p21 promoter and acts synergistically with Sp1 to induce transcription.
Basal transcription of the p21 gene in Caco-2 cells (Gartel et al., in preparation) and induction of the p21 promoter by E2F1 and E2F3 is mediated through the region of the promoter that contains multiple Sp1 binding sites. Since E2F1 DNA binding activity is required for activation, the E2F proteins may bind to the p21 promoter and directly activate transcription. Hiyama and colleagues (Hiyama et al., 1998) recently demonstrated that recombinant E2F1 and DP can bind to the sequence 5'-AAACGCGC-3' containing a partial E2F binding site (underlined) found in the E2F(b) sites noted in Figure 3c . It is also possible that the E2F proteins may transactivate genes encoding other factors responsible for p21 activation, such as Sp1. To address this possibility, we examined the levels of endogenous Sp1 and p21 mRNA expressed in Caco-2 cells following transfection with the E2F1 expression construct and we detected no increase in Sp1 mRNA levels, while p21 levels increased approximately threefold (Figure 4c ). Thus, transiently expressed E2F1 is capable of inducing expression of the endogenous p21 gene, and does not appear to transactivate the p21 promoter indirectly by activating the Sp1 gene.
The novel RB family binding protein HBP1 represses p21 transcription through cis-acting elements located between 7119 and +16 bp.
Recently, Tevosian et al. (1997) demonstrated that the novel RB and p130 binding protein HBP1 represses the N-Myc promoter and represents a transcriptional signal that can directly oppose E2F1 activation of critical cell cycle genes (Tevosian et al., 1997) . Because E2F1 strongly activated the p21 promoter, we asked if HBP1 could also repress expression of p21. The p21 promoter was repressed by HBP1 expression. Intriguingly, the p21 promoter sequences required for both E2F1 activation and HBP1 repression appear identical. To identify regions of the p21 promoter that are responsible for repression by HBP1, Caco-2 cells were transfected with constructs containing varying lengths of the p21 promoter (Figure 2a ) and the wild type HBP1 expression construct. All tested p21 promoter constructs were repressed 2 ± 3 times by HBP1 ( Figure  5 ). This level of repression does not depend upon the (7) or transfected with the E2F1 expression construct (+) using the human S14 ribosomal protein expression as an internal control. The EtBr stained gel with the bands corresponding to the dierent transcripts is shown eciency of transfection of the Caco-2 cells by the dierent constructs. Thus, HBP1 represses the p21 promoter through sequences between 7119 and +16 bp of the p21 gene.
HBP1 acts in opposition to E2F and its HMG box is necessary, but not sucient for repression of the p21 promoter
To test if HBP1 could act in opposition to E2F, we expressed dierent HBP expression constructs ( Figure  6a ) with the minimal p21 promoter construct (CAT119) and the E2F1 expression construct. As shown in Figure 6b , wild type HBP1 repressed the p21 promoter in the presence of exogenous E2F1.
To identify the domains of HBP1 required for repression, the activities of several mutant HBP1 constructs (Tevosian et al., 1997 ; diagrammed in Figure 6a ), were tested. The pmHMG construct encodes full length HBP1 with a triple point mutation resulting in disruption of its DNA binding activity, while the HMG box represents the DNA binding domain alone. HBP1 expressed from the pmL/IXC construct has point mutations in its LXCXE and IXCXE motifs, rendering it incapable of interacting with RB. Repression of the p21 promoter by HBP1 required an intact HMG box DNA binding domain (pm HMG) (Figure 6b) . However, the HMG box alone (HMG box) did not have repressor activity. Mutation of the two RB-binding motifs (pm L/IXC) did not aect p21 repression, and suggested that repression of the p21 promoter was independent of RB in these cells ( Figure  6b ). Thus, HBP1 could repress E2F activated transcription of the p21 promoter and the HMG box of HBP1 is necessary, but not sucient for this repression.
To quantitatively estimate the degree of HBP1 induced repression of the minimal p21 promoter, we cotransfected increasing concentrations of HBP1 with the reporter plasmid CAT119 and 2 mg of the E2F1 expression vector. We found that HBP1 may repress the p21 promoter up to sevenfold, and the level of repression by HBP1 depends on the concentration of HBP1 (Figure 6c ).
Discussion
Members of the RB family (RB, p107, p130) bind a variety of target proteins, including members of the E2F family (Slansky and Farnham, 1996) and HBP1 (Lavender et al., 1997; Tevosian et al., 1997) . Release of these target proteins is induced when RB family proteins are phosphorylated by active Cdk-cyclin complexes. Ectopic expression of free E2F1 has been shown to result in the activation of a number of genes important for S-phase, and promotes cell cycle progression (Johnson et al., 1993; Qin et al., 1994 ). An alternate role for E2F1 as an inhibitor of proliferation has also been proposed (Sellers et al., 1995) , as the RB-E2F1 complex itself can bind E2F cisacting elements in genes required for cell cycle progression and act as a transcriptional repressor (Sellers et al., 1995; Weintraub et al., 1992 Weintraub et al., , 1995 . Disruption of E2F1 in mice results in hyperplasia and tumor formation (Field et al., 1996; Yamasaki et al., 1996) , further supporting a role for E2F as a negative regulator of the cell cycle. E2F1 7/7 mice display visible enlargement of the thymus and lymph nodes within one month after birth, and increased thymocyte proliferation in aging mice. These data imply that E2F1 may perform a role in suppressing cell proliferation, perhaps via activation of p21.
It has recently been suggested that induction of p21 transcription by E2Fs may re¯ect a positive role for p21 in cell proliferation where it may be acting as a Cdk/cyclin assembly factor (Hiyama et al., 1988) . Usually p21 acts as a negative regulator of cell-cycle progression (for reviews see Gartel et al., 1996b; Gartel and Tyner, 1998) . However, induction of p21 expression by mitogenic stimulation has been observed by several investigators (Mantel et al., 1996; Michieli et al., 1994; Nourse et al., 1994) . Thus far, the signi®cance of p21 induction following mitogenic activation of the cell cycle is not well understood. Proliferation of myeloid progenitor cells is compromised in mice lacking p21, suggesting a positive role for p21 in the proliferation of these cells (Mantel et al., 1996) . Since E2Fs may induce cell cycle progression, it is possible that induction of p21 by mitogenic stimuli is mediated through E2F. Experiments to test this hypothesis are currently in progress.
We demonstrate that E2F1 and E2F3 can activate expression of the Cdk inhibitor p21. E2F may induce expression of Cdk inhibitors as a general means of controlling free E2F levels in the cell. In addition to inducing p21 expression, ectopic E2F expression has also been shown to result in increased expression of a p16INK4A related transcript (Khleif et al., 1996) . A variety of data suggest a complex regulatory loop in which an E2F induces expression of Cdk inhibitors, which then inhibit Cdk activity and further activation of E2F target genes. p21 has been shown to inhibit E2F activity and activation of E2F dependent promoters including the DHFR, cdc2, E2F1 (Dimri et al., 1996) and cyclin A promoters (Spitkovsky et al., 1997) .
The novel RB and p130 binding protein HBP1 has been shown to repress the N-Myc promoter and act in opposition to E2F1 (Tevosian et al., 1997) . Here, we show that HBP1 acts in opposition to E2F and represses basal and induced activity of the p21 promoter up to sevenfold. We found that the HBP1 DNA binding domain is required, but not sucient for repression of the p21 promoter. While the Rb binding motifs of HBP1 appear to play some role in the repression of the N-Myc promoter, repression of the p21 promoter in Caco-2 cells appears to be independent of RB binding. Overexpression of HBP1 may result in cellular transformation in certain cell lines (Lavender et al., 1997) , which could be due in part to the negative regulation of growth suppressing genes such as p21.
We have determined that both positive and negative regulation of p21 transcription by E2F1/E2F3 and HBP1 in Caco-2 cells requires only sequences extending to 7119 bp of the p21 gene. The sequence of the human p21 promoter from 7180 to +20 bp is diagrammed in Figure 3c . No sequence with a high degree of similarity to the known HBP1 binding site (TCAATGGG (Tevosian et al., 1997) was found in the p21 promoter. In addition, no canonical E2F consensus sites (5'-TTTCGCGC-3') were found, although a few partial sites (5'-CGCGC-3') were noted. Recently Hiyama et al., also found that E2F1 could activate the p21 promoter, and these authors proposed that this occurs through binding of E2F1 to noncanonical E2F binding sites that they termed E2F(a) and E2F(b) in the p21 promoter (Figure 3c ). We found that deletion of the E2F(a) site (5'-CTCCGCGC-3', Hiyama et al., 1998) located between 7156 and 7149 bp of p21 promoter did not change the degree of activation of the p21 promoter by E2F1 and E2F3 (Figure 2 , compare CAT133 and CAT296).
Two E2F(b) sites (Hiyama et al., 1998) and four Sp1 sites are located between 7119 and 760 bp of the p21 gene ( Figure 3c ). As shown in Figure 3b , deletion of these sites greatly reduces E2F1 and E2F3 responsiveness. Two Sp1 sites and one E2F(b) site that are located between 761 bp and the start of transcription do not appear to be necessary for activation of the p21 promoter by E2F1, but they may be important for activation by E2F3.
Sp1 is a zinc-®nger DNA binding protein that has been shown to play an important role in the regulation of p21 transcription. Sp1 mediates induction of the p21 gene in response to phorbol ester and okadaic acid (Biggs et al., 1996) , butyrate (Nakano et al., 1997), lovastatin (Lee et al., 1998) and TGF-b (Li et al., 1998) , while the related factor Sp3 mediates induction of the p21 gene in response to calcium (Prowse et al., 1997) . It has been shown that Sp1 can bind to E2F1, E2F2, and E2F3, but not E2F4 and E2F5 in vitro (Karlseder et al., 1996) . Here we show that E2F1 and E2F3 can strongly transactivate the p21 promoter, and it is possible that E2F1 and E2F3 induce p21 transcription by interacting with Sp1 and directing transcription through distinct Sp1 binding sites. We found that E2F1 DNA-binding activity is required for transactivation of the p21 promoter. In addition, interaction of E2F1 with Sp1 can further increase levels of induction of the p21 promoter. Similarly, in the context of the HSV TK promoter that is largely dependent on the Sp1 sites, E2F1 activates transcription in the absence of canonical E2F sites through the Sp1 sites and requires the E2F1 N-terminal domain that supports Sp1 interaction (Lin et al., 1996b; Shin et al., 1996) . Negative regulation of p21 transcription by HBP1 also requires the region of the promoter containing six Sp1 binding sites. The opposing activities of E2F1 and HBP1 suggest an intriguing positive/negative transcriptional regulatory network involving these RB binding proteins.
Materials and methods
Plasmid constructs
The human p21 WAF1/CIP1 promoter deletion-CAT reporter constructs in pJFCAT1 from CAT2330 to CAT296 ( Figure  2a) were a gift from WS El-Deiry (Univ of Pennsylvania) (El-Deiry et al., 1995) . Plasmids CAT133, CAT119 (Figure  2a ), CAT102 and CATD7124/760 ( Figure 3a) were a gift from J Biggs and A Kraft (Univ. of Colorado) (Biggs et al., 1996) . These plasmids contain dierent fragments of the p21 promoter, with the longest fragment from 72330 to +16 bp (CAT2330) and shortest from 7102 to +16 bp (CAT102). HBP expression constructs were created in the pEF-BOS vector (Tevosian et al., 1997) (Figure 6a ). E2F1 was cloned into pRc/CMV (Invitrogen). E2F1 and E2F3 were cloned into CMV expression vectors and were gifts from J Lees (MIT) (Moberg et al., 1996) . The E2F1 deletion mutants CMV-d113 ± 120 and E132 were a gift from J. Nevins (Duke Univ.) (Johnson et al., 1993) . To monitor eciency of transfections, the lac Z expression construct pCH110 (Pharmacia) was co-transfected.
Cell culture, transfections and CAT assays
The Caco-2 human colon adenocarcinoma cell line was obtained from the American Type Culture Collection and grown in DMEM/F12 with 20% fetal calf serum. Transient transfections of undierentiated Caco-2 cells (2 days after plating) were performed using calcium phosphate precipitation with 2 ± 4 mg of reporter plasmid, 2 ± 15 mg of expression vector plasmid and 3 mg of pCH110. Cells were harvested 48 ± 72 h after transfection, cellular extracts were prepared and CAT assays were performed as described previously (Gorman et al., 1982) . As a substrate for CAT assays we used 1-deoxy [
14 C]chloramphenicol (Amersham) instead of [ 14 C]chloramphenicol. A CAT assay using deoxychloramphenicol results in only one acetylated product, which makes it easier to quantify the results (Murray et al., 1991) . The per cent of acetylation in each experiment was calculated using a Betascope 603 (Betagen). Variations in transfection eciency were corrected by normalization for expression of b-galactosidase. All transfections were repeated at least three times in duplicate.
RNA preparation and RT ± PCR
Total RNA was prepared from Caco-2 cells by a singlestep method using RNAzol TM B (TEL-TEST, INC). For synthesis of cDNA we used the SuperScript TM Preamplification System (Gibco ± BRL). 2 mg of total cellular RNA was annealed with 50 ng of random hexadeoxynucleotide primer at 708C for 10 min. cDNA was synthesized in 20 ml solution containing 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 10 mM DTT, 500 mM dNTP and 200 units of SuperScript II reverse transcriptase at 428C for 50 min, after which we added two units of RNAse H. 2.5 ml of cDNA product was added to 30 ml of PCR reaction mixture that contained 200 mM dNTP, 2.5 mM MgCl 2 , 75 pmol primers, 1.5 units of AmpliTaq Polymerase (Gibco ± BRL). Each cycle of PCR included 45 s of denaturation at 948C, 1 min of primer annealing at dierent temperatures for each primer pair, and 1 min of extension/synthesis at 728C. For each combination of primers the kinetics of PCR ampli®cation was studied, the number of cycles corresponding to plateau were determined, and PCR was performed at an exponential range. We analysed expression of the human S14 ribosomal protein as internal control (Foley et al., 1993) . PCR products were separated on a 2% agarose gel and stained with ethidium bromide.
